Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case-control study.

Bhuiyan MU, Snelling TL, West R, Lang J, Rahman T, Granland C, de Gier C, Borland ML, Thornton RB, Kirkham LS, Sikazwe C, Martin AC, Richmond PC, Smith DW, Jaffe A, Blyth CC.

Thorax. 2018 Oct 18. pii: thoraxjnl-2018-212096. doi: 10.1136/thoraxjnl-2018-212096. [Epub ahead of print]

PMID:
30337417
2.

Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants.

Pomat WS, van den Biggelaar AHJ, Wana S, Greenhill AR, Ford R, Orami T, Passey M, Jacoby P, Kirkham LA, Lehmann D, Richmond PC; 10v13v PCV trial team.

Clin Infect Dis. 2018 Sep 3. doi: 10.1093/cid/ciy743. [Epub ahead of print]

PMID:
30184183
3.

Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program.

Marshall HS, Clarke M, Heath C, Quinn H, Richmond PC, Crawford N, Elliott E, Toi C, Kynaston A, Booy R, Macartney K; PAEDS investigators.

J Infect Dis. 2018 Sep 3. doi: 10.1093/infdis/jiy518. [Epub ahead of print]

PMID:
30184182
4.

The impact of influenza infection on young children, their family and the health care system.

Willis GA, Preen DB, Richmond PC, Jacoby P, Effler PV, Smith DW, Robins C, Borland ML, Levy A, Keil AD, Blyth CC; WAIVE Study Team.

Influenza Other Respir Viruses. 2018 Aug 23. doi: 10.1111/irv.12604. [Epub ahead of print]

5.

Evidence of functional cell-mediated immune responses to nontypeable Haemophilus influenzae in otitis-prone children.

Seppanen E, Tan D, Corscadden KJ, Currie AJ, Richmond PC, Thornton RB, Kirkham LS.

PLoS One. 2018 Apr 5;13(4):e0193962. doi: 10.1371/journal.pone.0193962. eCollection 2018.

6.

Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocol.

Bhuiyan MU, Snelling TL, West R, Lang J, Rahman T, Borland ML, Thornton R, Kirkham LA, Sikazwe C, Martin AC, Richmond PC, Smith DW, Jaffe A, Blyth CC.

BMJ Open. 2018 Mar 16;8(3):e020646. doi: 10.1136/bmjopen-2017-020646.

7.

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.

Lehmann D, Kirarock W, van den Biggelaar AHJ, Passey M, Jacoby P, Saleu G, Masiria G, Nivio B, Greenhill A, Orami T, Francis J, Ford R, Kirkham LA, Solomon V, Richmond PC, Pomat WS; 10v13v PCV trial team.

Pneumonia (Nathan). 2017 Dec 25;9:20. doi: 10.1186/s41479-017-0044-z. eCollection 2017.

8.

Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.

Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, Andrews RM, McIntyre PB; Australian Technical Advisory Group on Immunisation (ATAGI) Meningococcal Working Party.

Med J Aust. 2017 Nov 6;207(9):382-387.

PMID:
29092704
9.

Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.

Mowlaboccus S, Mullally CA, Richmond PC, Howden BP, Stevens K, Speers DJ, Keil AD, Bjørnstad ON, Perkins TT, Kahler CM.

PLoS One. 2017 Oct 24;12(10):e0186839. doi: 10.1371/journal.pone.0186839. eCollection 2017.

10.

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.

van den Biggelaar AHJ, Richmond PC, Fuery A, Anderson D, Opa C, Saleu G, Lai M, Francis JP, Alpers MP, Pomat WS, Lehmann D.

PLoS One. 2017 Oct 13;12(10):e0185877. doi: 10.1371/journal.pone.0185877. eCollection 2017.

11.

Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding.

Torresi J, Richmond PC, Heron LG, Qiao M, Marjason J, Starr-Spires L, van der Vliet D, Jin J, Wartel TA, Bouckenooghe A.

J Infect Dis. 2017 Oct 17;216(7):834-841. doi: 10.1093/infdis/jix314.

PMID:
28968794
12.

A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study.

Francis JP, Richmond PC, Michael A, Siba PM, Jacoby P, Hales BJ, Thomas WR, Lehmann D, Pomat WS, van den Biggelaar AHJ.

Pneumonia (Nathan). 2016 Aug 15;8:12. doi: 10.1186/s41479-016-0014-x. eCollection 2016.

13.

Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients.

Hung TY, Kotecha RS, Blyth CC, Steed SK, Thornton RB, Ryan AL, Cole CH, Richmond PC.

Cancer. 2017 Nov 1;123(21):4215-4223. doi: 10.1002/cncr.30764. Epub 2017 Jul 11.

PMID:
28696530
14.

Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens.

Thornton RB, Kirkham LS, Corscadden KJ, Wiertsema SP, Fuery A, Jones BJ, Coates HL, Vijayasekaran S, Zhang G, Keil A, Richmond PC.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00556-16. doi: 10.1128/CVI.00556-16. Print 2017 Apr.

15.

Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides.

Kirkham LS, Wiertsema SP, Corscadden KJ, Mateus T, Mullaney GL, Zhang G, Richmond PC, Thornton RB.

Clin Vaccine Immunol. 2017 Mar 6;24(3). pii: e00497-16. doi: 10.1128/CVI.00497-16. Print 2017 Mar.

16.

No evidence for impaired humoral immunity to pneumococcal proteins in Australian Aboriginal children with otitis media.

Thornton RB, Kirkham LS, Corscadden KJ, Coates HL, Vijayasekaran S, Hillwood J, Toster S, Edminston P, Zhang G, Keil A, Richmond PC.

Int J Pediatr Otorhinolaryngol. 2017 Jan;92:119-125. doi: 10.1016/j.ijporl.2016.11.019. Epub 2016 Nov 22.

17.

Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.

Francis JP, Richmond PC, Strickland D, Prescott SL, Pomat WS, Michael A, Nadal-Sims MA, Edwards-Devitt CJ, Holt PG, Lehmann D, van den Biggelaar AH.

Clin Exp Immunol. 2017 Mar;187(3):408-417. doi: 10.1111/cei.12902. Epub 2016 Dec 18.

18.

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial.

Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee SS, Perez JL; 6108A12001 Study Investigators.

Lancet Infect Dis. 2017 Jan;17(1):58-67. doi: 10.1016/S1473-3099(16)30314-0. Epub 2016 Oct 11.

PMID:
27745812
19.

Viral Etiology and the Impact of Codetection in Young Children Presenting With Influenza-Like Illness.

Lim FJ, Wake ZV, Levy A, Tempone S, Moore HC, Richmond PC, de Klerk N, Conway NT, Keil AD, Effler PV, Smith DW, Blyth CC; WAIVE group.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):260-266. doi: 10.1093/jpids/piw042.

PMID:
27440506
20.

Duplex Quantitative PCR Assay for Detection of Haemophilus influenzae That Distinguishes Fucose- and Protein D-Negative Strains.

de Gier C, Pickering JL, Richmond PC, Thornton RB, Kirkham LA.

J Clin Microbiol. 2016 Sep;54(9):2380-3. doi: 10.1128/JCM.00982-16. Epub 2016 Jun 22.

Supplemental Content

Loading ...
Support Center